Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-01

Clinical Trial Update: A FIH Study to Investigate the Safety, Tolerability and PK of P218 [Phase 1]

View source ↗

Summary

Phase 1 trial update for a first-in-human study evaluating safety, tolerability, and pharmacokinetics of P218 in malaria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • P218 (P218)

Snippet

Sponsor: Medicines for Malaria Venture | Conditions: Malaria | Phase 1 | Status: COMPLETED | Results posted: 2019-08-01